Ignore this story entirely unless you're a Tennessee resident interested in psychedelic research policy—it has no bearing on federal constitutional integrity.
This is a state-level clinical research policy change with zero constitutional governance impact. While it generates mild media interest due to drug classification novelty, it involves no federal action, no institutional capture, and no distraction timing pattern. This is legitimate state health policy experimentation.